- Country: Ukraine
- Summary: Ліки: Adalimumab; Tocilizumab; Tofacitinib
- UAT Ref No: 127152889
- Deadline: 07 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 5342337
- Notice Type: Tender
- Document Ref. No.: UA-2025-09-26-012882-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Type of purchase: goods
filled with a single -dose syringe, 1 syringe together with 1 napkin, soaked in 70 % isopropyl alcohol (in laminated polyethylene paper), place in contour cellular packaging; injections, 40 mg/0.4 ml; isopropylov alcohol (in laminated polyethylene paper), placed in contour cellular packaging; cardboard box or "equivalent", Aktemra(r) concentrate for infusion solution, 20 mg/ml; box or "equivalent", Xelianz tablets covered with a film sheath, 5 mg; 14 tablets in blister; "equivalent - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINЛіки: Adalimumab; Tocilizumab; Tofacitinib - Ukraine Tender
The STATE INSTITUTION ALL -UKRAINIAN CENTER FOR MATERNITY AND CHILDHOOD OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE, a Government sector organization in Ukraine, has announced a new tender for Ліки: Adalimumab; Tocilizumab; Tofacitinib. This tender is published on UkraineTenders under UAT Ref No: 127152889 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-07.
The estimated tender value is UAH 5342337, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
